Brain injury in chronically ventilated preterm neonates: Collateral damage related to ventilation strategy

Clinics in Perinatology

Volumn 39, Issue 3, 2012, Pages 727-740

  Albertine, Kurt H ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchopulmonary dysplasia; Gray matter injury; Neonatal chronic lung disease; White matter injury

Indexed keywords

CORTICOSTEROID;

ARTIFICIAL VENTILATION; BABOON; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN INJURY; CHILD DEATH; CHROMATIN; CHRONIC LUNG DISEASE; COMORBIDITY; DISEASE SEVERITY; ENCEPHALOMALACIA; ENDOTRACHEAL INTUBATION; EPIGENETICS; EXPERIMENTAL MODEL; EXTUBATION; GAS EXCHANGE; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GESTATIONAL AGE; GRAY MATTER LESION; HIGH FREQUENCY VENTILATION; HISTONE MODIFICATION; HUMAN; HYDROCEPHALUS; INTRAUTERINE GROWTH RETARDATION; LAMB; LONG TERM CARE; LUNG DYSPLASIA; MOLECULAR MECHANICS; NEWBORN DISEASE; OXYGENATION; POSITIVE END EXPIRATORY PRESSURE; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; REVIEW; VENTILATOR; WHITE MATTER LESION;

ANIMALS; BRAIN; BRAIN INJURIES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG DISEASES; RESPIRATION, ARTIFICIAL;

EID: 84865712559     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2012.06.017     Document Type: Review

References (104)

1. Walsh M.C., Morris B.H., Wrage L.A., et al. Extremely low birthweight neonates with protracted ventilation: mortality and 18-month neurodevelopmental outcomes. J Pediatr 2005, 146:798-804.
2. Banker B.Q., Larroche J.C. Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy. Arch Neurol 1962, 7:386-410.
3. Perlman J.M. Neurobehavioral deficits in premature graduates of intensive care-potential medical and neonatal environmental risk factors. Pediatrics 2001, 108:1339-1348.
4. Pierson C.R., Folkerth R.D., Billiards S.S., et al. Gray matter injury associated with periventricular leukomalacia in the premature infant. Acta Neuropathol 2007, 114:619-631.
5. Taylor H.G., Burant C.J., Holding P.A., et al. Sources of variability in sequelae of very low birth weight. Child Neuropsychol 2002, 8:163-178.
6. Mathews T.J., MacDorman M.F. Infant mortality statistics from the 2007 period linked birth/infant death data set. Natl Vital Stat Rep 2011, 59:1-30.
7. Avery M.E., Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959, 97:517-523.
8. Liggins G.C., Howie R.N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972, 50:515-520.
9. Merritt T.A., Hallman M., Bloom B.T., et al. Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 1986, 315:785-790.
10. Enhorning G., Shennan A., Possmayer F., et al. Prevention of neonatal respiratory distress syndrome of tracheal instillation of surfactant: a randomized clinical trial. Pediatrics 1985, 76:145-153.
11. Husain A.N., Siddiqui N.H., Stocker J.T. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1988, 29:710-717.
12. Jobe A.H. Pulmonary surfactant therapy. NEJM 1993, 328:861-868.
13. Kwong M.S., Egan E.A., Notter R.H., et al. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 1985, 76:585-592.
14. Avery M.E., Tooley W.H., Keller J.B., et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987, 79:26-30.
15. Dani C., Bertini G., Pezzati M., et al. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics 2004, 113:e560-e563.
16. Gregory G.A., Kitterman J.A., Phibbs R.H., et al. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. NEJM 1971, 284:1333-1340.
17. Van Marter L.J., Allred E.N., Pagano M., et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000, 105:1194-1201.
18. Albertine K.H., Pysher T.J. Impaired lung growth after injury in premature lung. Fetal and neonatal physiology 2011, 1039-1047. Elsevier Science, New York. 4th edition. R.A. Polin, W.W. Fox, S. Abman (Eds.).
19. Northway W.H., Rosan R.C., Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. NEJM 1967, 276:357-368.
20. Biagioni E., Frisone M.F., Laroche S., et al. Maturation of cerebral electrical activity and development of cortical folding in young very preterm infants. Clin Neurophysiol 2007, 118:53-59.
21. Flores Guevara R., Giannuzzi R., de Oliveira Nosralla M., et al. Positive slow waves in the EEG of premature infants between 24 and 36 weeks of conceptional age. Clin Neurophysiol 2008, 119:180-189.
22. Katz L.C., Crowley J.C. Development of cortical circuits: lessons from ocular dominance columns. Nat Rev Neurosci 2002, 3:34-42.
23. Khazipov R., Sirota A., Leinekugel X., et al. Early motor activity drives spindle bursts in the developing somatosensory cortex. Nature 2004, 432:758-761.
24. Milh M., Kaminska A., Huon C., et al. Rapid cortical oscillations and early motor activity in premature human neonate. Cereb Cortex 2007, 17:1582-1594.
25. Mirro R., Leffler C.W., Armstead W.M., et al. Positive-pressure ventilation alters blood-to-brain and blood-to-CSF transport in neonatal pigs. J Appl Physiol 1991, 70:584-589.
26. Hambleton G., Wigglesworth J.S. Origin of intraventricular haemorrhage in the preterm infant. Arch Dis Child 1976, 51:651-659.
27. Stonestreet B.S., McKnight A.J., Sadowska G., et al. Effects of duration of positive-pressure ventilation on blood-brain barrier function in premature lambs. J Appl Physiol 2000, 88(5):1672-1677.
28. Hagberg H., Peebles D., Mallard C. Models of white matter injury: comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 2002, 8:30-38.
29. Mallard C., Welin A.K., Peebles D., et al. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res 2003, 28:215-223.
30. Perlman J.M., Volpe J.J. Cerebral blood flow velocity in relation to intraventricular hemorrhage in the premature newborn infant. J Pediatr 1982, 100:956-959.
31. Funato M., Tamai H., Noma K., et al. Clinical events in association with timing of intraventricular hemorrhage in preterm infants. J Pediatr 1992, 121:614-619.
32. Osborn D.A., Evans N., Kluckow M. Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics 2003, 112:33-39.
33. Watkins A.M., West C.R., Cooke R.W. Blood pressure and cerebral haemorrhage and ischaemia in very low birthweight infants. Early Hum Dev 1989, 19:103-110.
34. Ando M., Takashima S., Mito T. Endotoxin, cerebral blood flow, amino acids and brain damage in young rabbits. Brain Dev 1988, 10:365-370.
35. Gilles F.H., Averill D.R., Kerr C.S. Neonatal endotoxin encephalopathy. Ann Neurol 1977, 2:49-56.
36. Kaiser J.R., Gauss C.H., Williams D.K. Surfactant administration acutely affects cerebral and systemic hemodynamics and gas exchange in very-low-birth-weight infants. J Pediatr 2004, 144:809-814.
37. Lou H.C., Lassen N.A., Friis-Hansen B. Impaired autoregulation of cerebral blood flow in the distressed newborn infant. J Pediatr 1979, 94:118-121.
38. Marlow N., Wolke D., Bracewell M.A., et al. Neurologic and developmental disability at six years of age after extremely preterm birth. NEJM 2005, 352:9-19.
39. Pryds O., Andersen G.E., Friis-Hansen B. Cerebral blood flow reactivity in spontaneously breathing, preterm infants shortly after birth. Acta Paediatr Scand 1990, 79:391-396.
40. Pryds O., Greisen G., Lou H., et al. Heterogeneity of cerebral vasoreactivity in preterm infants supported by mechanical ventilation. J Pediatr 1989, 115:638-645.
41. Tsuji M., Saul J.P., du Plessis A., et al. Cerebral intravascular oxygenation correlates with mean arterial pressure in critically ill premature infants. Pediatrics 2000, 106:625-632.
42. Yoshioka H., Goma H., Sawada T. No To Hattatsu 1996, 28:128-129. [in Japanese].
43. Coughtrey H., Rennie J.M., Evans D.H. Variability in cerebral blood flow velocity: observations over one minute in preterm babies. Early Hum Dev 1997, 47:63-70.
44. Perlman J., Thach B. Respiratory origin of fluctuations in arterial blood pressure in premature infants with respiratory distress syndrome. Pediatrics 1988, 81:399-403.
45. Dommergues M.A., Patkai J., Renauld J.C., et al. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 2000, 47:54-63.
46. Eklind S., Mallard C., Leverin A.L., et al. Bacterial endotoxin sensitizes the immature brain to hypoxic-ischaemic injury. Eur J Neurosci 2001, 13:1101-1106.
47. Hedtjarn M., Leverin A.L., Eriksson K., et al. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002, 22:5910-5919.
48. Rezaie P., Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002, 22:106-132.
49. Hudome S., Palmer C., Roberts R.L., et al. The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr Res 1997, 41:607-616.
50. Liu X.H., Kwon D., Schielke G.P., et al. Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab 1999, 19:1099-1108.
51. Palmer C., Menzies S.L., Roberts R.L., et al. Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat. J Neurosci Res 1999, 56:60-71.
52. Barres B.A., Hart I.K., Coles H.S., et al. Cell death in the oligodendrocyte lineage. J Neurobiol 1992, 23:1221-1230.
53. Guan J., Bennet L., Gluckman P.D., et al. Insulin-like growth factor-1 and post-ischemic brain injury. Prog Neurobiol 2003, 70:443-462.
54. Loeliger M., Inder T., Cain S., et al. Cerebral outcomes in a preterm baboon model of early versus delayed nasal continuous positive airway pressure. Pediatrics 2006, 118:1640-1653.
55. Mathers J.C., McKay J.A. Epigenetics - potential contribution to fetal programming. Adv Exp Med Biol 2009, 646:119-123.
56. Zeisel S.H. Epigenetic mechanisms for nutrition determinants of later health outcomes. Am J Clin Nutr 2009, 89:1488S-1493S.
57. Joss-Moore L.A., Albertine K.H., Lane R.H. Epigenetics and the developmental origins of lung disease. Mol Genet Metab 2011, 104:61-66.
58. Fu Q., Yu X., Callaway C.W., et al. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J 2009, 23:2438-2449.
59. Luger K., Mader A.W., Richmond R.K., et al. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997, 389:251-260.
60. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
61. Roth D.M., Balch W.E. Modeling general proteostasis: proteome balance in health and disease. Curr Opin Cell Biol 2011, 23:126-134.
62. Marmorstein R., Trievel R.C. Histone modifying enzymes: structures, mechanisms, and specificities. Biochim Biophys Acta 2009, 1789:58-68.
63. Ito S., D'Alessio A.C., Taranova O.V., et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466:1129-1133.
64. Tahiliani M., Koh K.P., Shen Y., et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
65. Cedar H., Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009, 10:295-304.
66. Sato F., Tsuchiya S., Meltzer S.J., et al. MicroRNAs and epigenetics. FEBS J 2011, 278:1598-1609.
67. Aagaard-Tillery K.M., Grove K., Bishop J., et al. Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome. J Mol Endocrinol 2008, 41:91-102.
68. Reyburn B., Li M., Metcalfe D.B., et al. Nasal ventilation alters mesenchymal cell turnover and improves alveolarization in preterm lambs. Am J Respir Crit Care Med 2008, 178:407-418.
69. Lallemand A.V., Ruocco S.M., Joly P.M., et al. In vivo localization of the insulin-like growth factors I and II (IGF I and IGF II) gene expression during human lung development. Int J Dev Biol 1995, 39:529-537.
70. Chetty A., Andersson S., Lassus P., et al. Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD. Pediatr Pulmonol 2004, 37:128-136.
71. Ke X., Lei Q., James S.J., et al. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol Genomics 2006, 25:16-28.
72. Woods K.A., Camacho-Hubner C., Barter D., et al. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature. Acta Paediatr Suppl 1997, 423:39-45.
73. Barkho B.Z., Song H., Aimone J.B., et al. Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation. Stem Cells Dev 2006, 15:407-421.
74. Gluckman P., Klempt N., Guan J., et al. A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun 1992, 182:593-599.
75. Mozell R.L., McMorris F.A. Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures. J Neurosci Res 1991, 30:382-390.
76. Ye P., Li L., Richards R.G., et al. Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci 2002, 22:6041-6051.
77. Volpe J.J. Overview: normal and abnormal human brain development. Ment Retard Dev Disabil Res Rev 2000, 6:1-5.
78. Colas J.F., Schoenwolf G.C. Towards a cellular and molecular understanding of neurulation. Dev Dyn 2001, 221:117-145.
79. Smith J.L., Schoenwolf G.C. Neurulation: coming to closure. Trends Neurosci 1997, 20:510-517.
80. Mollgard K., Saunders N.R. The development of the human blood-brain and blood-CSF barriers. Neuropathol Appl Neurobiol 1986, 12:337-358.
81. Kostovic I., Judas M. Correlation between the sequential ingrowth of afferents and transient patterns of cortical lamination in preterm infants. Anat Rec 2002, 267:1-6.
82. Gressens P. Mechanisms and disturbances of neuronal migration. Pediatr Res 2000, 48:725-730.
83. Gressens P., Richelme C., Kadhim H.J., et al. The germinative zone produces the most cortical astrocytes after neuronal migration in the developing mammalian brain. Biol Neonate 1992, 61:4-24.
84. Rakic P. Developmental and evolutionary adaptations of cortical radial glia. Cereb Cortex 2003, 13:541-549.
85. Rakic P. Specification of cerebral cortical areas. Science 1988, 241:170-176.
86. Sidman R.L., Rakic P. Neuronal migration, with special reference to developing human brain: a review. Brain Res 1973, 62:1-35.
87. Miyawaki T., Matsui K., Takashima S. Developmental characteristics of vessel density in the human fetal and infant brains. Early Hum Dev 1998, 53:65-72.
88. Changeux J.P., Danchin A. Selective stabilisation of developing synapses as a mechanism for the specification of neuronal networks. Nature 1976, 264:705-712.
89. Battin M.R., Maalouf E.F., Counsell S.J., et al. Magnetic resonance imaging of the brain in very preterm infants: visualization of the germinal matrix, early myelination, and cortical folding. Pediatrics 1998, 101:957-962.
90. Childs A.M., Ramenghi L.A., Evans D.J., et al. MR features of developing periventricular white matter in preterm infants: evidence of glial cell migration. AJNR Am J Neuroradiol 1998, 19:971-976.
91. Volpe J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 2001, 50:553-562.
92. Inage Y.W., Itoh M., Takashima S. Correlation between cerebrovascular maturity and periventricular leukomalacia. Pediatr Neurol 2000, 22:204-208.
93. McQuillen P.S., Sheldon R.A., Shatz C.J., et al. Selective vulnerability of subplate neurons after early neonatal hypoxia-ischemia. J Neurosci 2003, 23:3308-3315.
94. Volpe J.J. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009, 8:110-124.
95. Dommergues M.A., Plaisant F., Verney C., et al. Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection. Neuroscience 2003, 121:619-628.
96. Haynes R.L., Folkerth R.D., Trachtenberg F.L., et al. Nitrosative stress and inducible nitric oxide synthase expression in periventricular leukomalacia. Acta Neuropathol 2009, 118:391-399.
97. Kadhim H., Tabarki B., Verellen G., et al. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001, 56:1278-1284.
98. Merrill J.E., Ignarro L.J., Sherman M.P., et al. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993, 151:2132-2141.
99. Perlman J.M. White matter injury in the preterm infant: an important determination of abnormal neurodevelopment outcome. Early Hum Dev 1998, 53:99-120.
100. Rezaie P., Male D. Colonisation of the developing human brain and spinal cord by microglia: a review. Microsc Res Tech 1999, 45:359-382.
101. Smith M.E., van der Maesen K., Somera F.P. Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production. J Neurosci Res 1998, 54:68-78.
102. Volpe J.J. Cerebral white matter injury of the premature infant-more common than you think. Pediatrics 2003, 112:176-180.
103. Tanaka F., Ozawa Y., Inage Y., et al. Association of osteopontin with ischemic axonal death in periventricular leukomalacia. Acta Neuropathol 2000, 100:69-74.
104. Volpe J.J. Subplate neurons-missing link in brain injury of the premature infant?. Pediatrics 1996, 97:112-113.